ARCH Venture Management, LLC
Source: SEC Form 13F · as of Mar 2026ARCH Venture Management, LLC holds 9 biotech & pharma companies tracked by BioSniper, totaling $672.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$672.5M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Maze Therapeutics, Inc. (MAZE)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| MAZEMaze Therapeutics, Inc. | 4,120,053 | $123.0M |
| RAPPRapport Therapeutics, Inc. | 3,728,738 | $116.7M |
| VIRVir Biotechnology, Inc. | 12,916,663 | $115.7M |
| ERASErasca, Inc. | 7,091,557 | $114.7M |
| BEAMBeam Therapeutics Inc. | 4,540,132 | $108.2M |
| LYELLyell Immunopharma, Inc. | 3,247,162 | $65.1M |
| GENBGenerate Biomedicines Inc. | 1,944,426 | $24.3M |
| GOSSGossamer Bio, Inc. | 8,055,916 | $2.6M |
| QTTBQ32 Bio Inc. | 320,482 | $2.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.